Comparison of Surveillance with Low-dose and Contrast-enhanced Chest Computed Tomography in Patients Disease-free for Two Years after Curative Resection for Lung Cancer
Cancer Research and Treatment · 2025
DOI: 10.4143/crt.2025.256 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Bubse Na und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Lung Neoplasms, Tomography, X-Ray Computed, Carcinoma, Non-Small-Cell Lung, Neoplasm Recurrence, Local. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Seoul National University Hospital.
Abstract (Originalsprache)
PURPOSE: Low-dose chest computed tomography (LDCT) is recommended for surveillance 2-3 years after curative resection of non-small cell lung cancer (NSCLC); however, supporting clinical evidence is limited. This study compared LDCT with contrast-enhanced chest computed tomography (CECT) in terms of recurrence detection and overall survival (OS) in patients 2 years after curative resection of NSCLC. MATERIALS AND METHODS: Among patients who underwent curative resection for NSCLC between January 2011 and December 2017 and survived for 2 years without recurrence, 2,083 patients were included. Comparisons between the LDCT and CECT groups were performed in both the entire cohort and propensity score-matched cohort. The primary outcome was the difference in overall survival. Secondary outcomes included time-to-recurrence, recurrence-free survival, and post-recurrence survival in each group. RESULTS: In the propensity score-matched population, the 5-year OS (96.0% for LDCT, 98.0% for CECT, p=0.097) and recurrence-free survival (RFS) (95.4% for LDCT, 96.0% for CECT, p=0.761) did not differ. The OS and RFS did not differ in subgroup analyses stratified by pathologic stage and histologic type. In the competing risk analysis, the overall 5-year cumulative incidence of recurrence did not differ between the two groups (4.56% for LDCT, 3.93% for CECT, p=0.765). When stratified by pathologic stage and histologic type, there was no significant difference in the cumulative incidence of recurrence. The distribution of recurrence sites did not differ between groups. CONCLUSION: Similar OS and RFS were observed in LDCT and CECT surveillance in patients who achieved a 2-year disease-free status after curative resection for NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Förderung
- Seoul National University Hospital
Zitieren
APA
Na, B., Park, J. H., Na, K. J., Park, S., Kang, C. H., Kim, Y. T., & Park, I. K. (2025). Comparison of Surveillance with Low-dose and Contrast-enhanced Chest Computed Tomography in Patients Disease-free for Two Years after Curative Resection for Lung Cancer. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.256
Vancouver
Na B, Park JH, Na KJ, Park S, Kang CH, Kim YT, et al. Comparison of Surveillance with Low-dose and Contrast-enhanced Chest Computed Tomography in Patients Disease-free for Two Years after Curative Resection for Lung Cancer. Cancer Research and Treatment. 2025. doi:10.4143/crt.2025.256
BibTeX
@article{Na2025,
author = {Na, Bubse and Park, Ji Hyeon and Na, Kwon Joong and Park, Samina and Kang, Chang Hyun and Kim, Young Tae and Park, In Kyu},
title = {Comparison of Surveillance with Low-dose and Contrast-enhanced Chest Computed Tomography in Patients Disease-free for Two Years after Curative Resection for Lung Cancer},
journal = {Cancer Research and Treatment},
year = {2025},
doi = {10.4143/crt.2025.256}
}
EUVIMED